Accelerate Diagnostics Annual Revenue, Competitors, Number of Employees and Funding

Claim your profile

Overview

Location:
Tucson, AZ USA
Total Funding:N/A
Industry:Medical Equip
Founded:2004
Lead Investor(s):N/A
Press
Claim your profile

Estimated Revenue & Financials

  • Accelerate Diagnostics's estimated annual revenue is currently $60.7M per year.
  • Accelerate Diagnostics's estimated revenue per employee is $251,000

Employee Data

  • Accelerate Diagnostics has 242 Employees.
  • Accelerate Diagnostics grew their employee count by -4% last year.
  • Accelerate Diagnostics currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Zounds
$18.3M73N/AN/A
Xeridiem Medica...
$8.5M34N/AN/A
Faxitron Biopti...
N/A40N/AN/A
Vante
N/A38N/AN/A
SmartPractice
$43.2M172N/AN/A
Machine Solutio...
$18.8M75N/AN/A
Ulthera
$15.8M63N/AN/A
Regenesis Biome...
$18.8M75N/AN/A
AdviNow Medical
$8.5M3417%N/A
Accelerate Diag...
$60.7M242-4%N/A
Missing a competitor? Contribute!?
Submit

Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.

keywords:N/A

242

Number of Employees

$60.7M

Revenue (est)

1

Current Jobs

-4%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Accelerate Diagnostics News

09/03/2019 - Accelerate Diagnostics Reports Second Quarter 2019 ...

TUCSON, Ariz., Aug. 8, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second ...

08/09/2019 - Accelerate Diagnostics, Inc.: The Snowball Effect Is Just ...

Accelerate Diagnostics (NASDAQ:AXDX) is finally approaching an inflection point in their unit sales of the Pheno system, and hospitals are ...

09/03/2019 - Putting Accelerate Diagnostics, Inc. (NasdaqCM:AXDX ...

Accelerate Diagnostics, Inc. (NasdaqCM:AXDX) has an ERP5 rank of 17303. The ERP5 Rank is an investment tool that analysts use to ...